1.5 Abstract su Rivista: [1053] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 1.053
Titolo Data di pubblicazione Autore(i) File
Reversion of mesenchymal behaviour by AZD9291 (osimertinib) in EGFR mutant NSCLC cell lines resistant to first generation EGFR tyrosine kinase inhibitors 1-gen-2016 Savastano, B; Della Corte, Cm; Papaccio, F; Giuseppe, V; Esposito, G; Fasano, M; Orditura, M; De Vita, F; Ciardiello, F; Morgillo, F
Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites 1-gen-2018 Morgillo, F; Della Corte, Cm; Viscardi, G; Di Liello, R; Papaccio, F; Ciardiello, F
ZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition 1-gen-2019 Valiente, Fg; Tarazona, N; Gambardella, V; Riffo-Campos, A; Papaccio, F; Cabeza-Segura, M; López-Rodas, G; Cervantes, A; Franco, L; Castillo, J
Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence 1-gen-2016 Esposito, G; Della Corte, Cm; Papaccio, F; Viscardi, G; Fasano, M; Troiani, T; Martinelli, E; Ciardiello, F; Morgillo, F
Met/Axl system as a dual target in the mesothelioma pathway and invasiveness 1-gen-2017 Viscardi, G; Ciaramella, V; Della Corte, Cm; Papaccio, F; Esposito, G; Di Liello, R; Troiani, T; Orditura, M; Ciardiello, F; Morgillo, F
Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor 1-gen-2020 Papaccio, F; Bravo, Mfg; Cabeza-Segura, M; Gimeno-Valiente, F; Gambardella, V; Garzón-Lloría, Z; García-Micó, B; Huerta, M; Martínez-Ciarpaglini, C; Alfaro-Cervello, C; Sabater, L; Lombardi, P; Rentero-Garrido, P; Zúñiga-Trejos, S; Keränen, Sr; Fleitas, T; Tarazona, N; Roda, D; Cervantes, A; Castillo, J
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy 1-gen-2017 Barra, G; Pasquale, G; Della Corte, C; Papaccio, F; Ciardiello, F; Morgillo, F; De Palma, R
A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC 1-gen-2019 Viscardi, G; Sparano, F; Di Liello, R; Casal, Ga; Ferreres, Rb; Bruixola, G; Gambardella, V; Zanaletti, N; Iacovino, Ml; Della Corte, Cm; Papaccio, F; Fasano, M; Ciardiello, F; Cervantes, A; Morgillo, F; Martorell, Pm; Molla, Mai
Role of the Hedgehog pathway in preventing occurrence of resistance to first, second, third generation EGFR-TKIs in first line therapy of NSCLC models with EGFR activating mutations 1-gen-2016 Viscardi, G; Della Corte, Cm; Papaccio, F; Esposito, G; Fasano, M; Martinelli, E; Troiani, T; Ciardiello, F; Morgillo, F
An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models 1-gen-2020 Gambardella, V; Gimeno-Valiente, F; Cabeza, M; Papaccio, F; Zúñiga-Trejos, S; Carbonell-Asins, Ja; Rentero-Garrido, P; Huerta, M; Keränen, Sr; Cejalvo, Jm; Roda, D; Tarazona, N; Fleitas, T; Cervantes, A; Castillo, J
3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients 1-gen-2020 Cabeza, M; Papaccio, F; Bravo, Mfg; Gambardella, V; Alfaro-Cervello, C; Martínez-Ciarpaglini, C; Garzón-Lloría, Z; Rentero-Garrido, P; Zúñiga-Trejos, S; Seda-García, E; Gimeno-Valiente, F; Peña, A; Barrios, M; Tarazona, N; Roda, D; Cervantes, A; Fleitas, T; Castillo, J
Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance 1-gen-2016 Papaccio, F; Della Corte, Cm; Viscardi, G; Esposito, G; Fasano, M; De Vita, F; Orditura, M; Ciardiello, F; Morgillo, F
Prognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC) 1-gen-2017 Bruixola, G; Caballero, J; Papaccio, F; Petrillo, A; Pastor, M; Cervantes, A
Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites 1-gen-2017 Della Corte, Cm; Barra, G; Ciaramella, V; Papaccio, F; Viscardi, G; Esposito, G; Di Liello, R; Orditura, M; Troiani, T; De Palma, R; Ciardiello, F; Morgillo, F
Results of safety run-in part in Metal (METformin in Advanced Lung cancer) trial 1-gen-2016 Fasano, M; Della Corte, Cm; Papaccio, F; Viscardi, G; Esposito, G; Troiani, T; Martinelli, E; Ciardiello, F; Morgillo, F
CNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations 1-gen-2019 Papaccio, F; Valiente, Fg; Gutierrez-Bravo, Mf; Cabeza-Segura, M; Gambardella, V; Huerta, Mds; Martinez-Ciarpaglini, C; Alfaro-Cervello, C; Rentero-Garrido, P; Zúñiga-Trejos, S; Keranen, Sr; Fleitas, T; Tarazona, N; Perez, Dr; Cervantes, A; Castillo, J
Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype 1-gen-2019 Llavero, Nt; Gimeno-Valiente, F; Gambardella, V; Huerta, M; Keranen, Sr; Bruixola, G; Fontana, E; Ciarpaglini, Cm; Zuñiga, S; Rentero, P; Fleitas, T; Papaccio, F; Moro, D; Pla, V; Nyamundanda, G; Castillo, J; Sadanadam, A; Espí, A; Roda, D; Cervantes, A
Antitumoral efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models 1-gen-2018 Morgillo, F; Della Corte, Cm; Alfieri, R; Petronini, P; La Monica, S; Papaccio, F; Ciardiello, F
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSCLC cancer: a preliminary study to identify biomarkers of efficacy 1-gen-2016 Barra, G; Pasquale, G; Della Corte, Cm; Papaccio, F; Orditura, M; Devita, F; Ciardiello, F; De Palma, R; Morgillo, F
Patient-derived organoids as a tool for modelling localized colorectal cancer 1-gen-2020 Bravo, Mfg; Papaccio, F; Cabeza, M; Martínez-Ciarpaglini, C; Alfaro-Cervello, C; Garzón-Lloría, Z; Ferrer-Martínez, A; García-Micó, B; Gambardella, V; Rentero-Garrido, P; Fleitas, T; Moro-Valdezate, D; Huerta, M; Tarazona, N; Roda, D; Cervantes, A; Castillo, J
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 1.053
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista1053
Autore
  • SELLERI, Carmine126
  • VAJRO, Pietro116
  • MONTELEONE, Palmiero86
  • CASOLARO, Vincenzo53
  • PACE, Leonardo43
  • VITALE, Mario40
  • STELLATO, Cristiana38
  • GIUDICE, VALENTINA36
  • IOVINO, Paola33
  • CIACCI, Carolina32
Data di pubblicazione
  • 2020 - 202453
  • 2010 - 2019413
  • 2000 - 2009321
  • 1990 - 1999208
  • 1980 - 198957
  • 1978 - 19791
Editore
  • wiley blackwell1
Rivista
  • HAEMATOLOGICA52
  • DIGESTIVE AND LIVER DISEASE48
  • JOURNAL OF ALLERGY AND CLINICAL I...45
  • BLOOD39
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...37
  • JOURNAL OF PEDIATRIC GASTROENTERO...37
  • ANNALS OF ONCOLOGY27
  • RIVISTA DI STUDI POLITICI INTERNA...26
  • BONE MARROW TRANSPLANTATION24
  • SPORT SCIENCES FOR HEALTH21
Keyword
  • pediatrics109
  • Humans3
  • Ring closure reactions3
  • rinvenimenti monetali3
  • Animals2
  • autologous bone graft2
  • Cardiovascular Diseases2
  • Interventional2
  • Medicinal chemistry2
  • Pharmacology2
Lingua
  • eng788
  • ita72
  • cze1
  • fre1
Accesso al fulltext
  • no fulltext1052
  • open1